Insight Article  |
Single Cell Analysis

Single Cell Proteomics: Sample Preparation and Tissue Selection

By Oliver Picken |
05 May 2022
Single-cell proteomics has developed quickly, despite being a relatively new field. NanoPOTS and FACS are being used to improve proteome coverage and minimise sample size.

Proteomics has faced many challenges for application at single-cell resolution. Other omics, such as genomics and transcriptomics, can use amplification to aid single-cell analysis. Unfortunately, proteins cannot be amplified, meaning that research is limited by the small number usable in a single cell. Proteins provide unique insight into cell structure and processes. Furthering single-cell proteomics is a top priority for many researchers and pharmaceutical companies.

Single-cell proteomics has developed quickly, despite being a relatively new field. Until the 2010s, protein levels in single cells were estimated using cellular mRNA levels or multi-cell samples. The high throughput methods used in other omics sciences have not yet been applied to single cell proteomics. Fortunately, novel proteomic approaches hold the promise of direct testing and new insights. Single-cell proteomics aims to observe protein interaction and changes directly, enabling a more complete understanding of cellular activities.

Miniaturisation and Sample Preparation: NanoPOTS

At Oxford Global’s 2022 single-cell proteomics workshop, Ryan Kelly, Associate Professor in the Department of Chemistry and Biochemistry at Brigham Young University, recounted his team’s work on NanoPOTS. His work aimed to minimise exposed surfaces and, therefore, nonspecific adsorptive losses through sample miniaturisation. He explains that “the approach that we hit on was basically keeping the benefits and the general form factor of conventional workflows, and just miniaturising it to reduce surface exposure volumes and, also incorporating a one pot sample preparation workflow. The acronym NanoPOTS stands for nano-droplet processing in one-pot for trace samples.”

The team recruited Ying Zhu to help with this. He had previously been developing a robotic nano pipetting platform. While his previous work involved using an oil cover, the new approach involved using a humidifying chamber for droplet dispensing. Kelly clarifies that this approach means that they are “only ever adding a reagent, incubating, and then adding the next reagent, so it all takes place in the same well.” While the initial publication did not get down to the single-cell level, the team achieved a proteome coverage of over 3000 protein groups in approximately ten cells, around 500 times more than any previous publication.

Single Cell Analysis: NanoPOTS and FACS

How to use NanoPOTS and FACS for Single Cell Proteomics

Shortly after their initial publication, Kelly’s group combined the NanoPOTS platform with fluorescence-activated cell sorting (FACS). They aimed to evaluate the potential of NanoPOTS for analysing proteins within single mammalian cells. He claims that “this works well if you have the right FACS system. I think for making spatial measurements, coupling with laser microdissection is also very valuable.”

Using FACS in tandem with NanoPOTS offers three main advantages. First, it allows far more precision when loading cells into each nanowell. Second, FACS reduces background contamination via cell suspension in a phosphate-buffered saline (PBS) solution. Third, FACS provides vital visualisation for biochemical analyses, allowing greater detection and isolation of specific cell types.

Based on MS/MS identifications, researchers initially identified 200 to 300 protein groups from 50 micrometres of material. Since then, advancements have pushed this number up significantly while leaving additional room for improvement.

Tissue Selection: Fresh Frozen or Formalin-Fixed Paraffin-Embedded?

Another essential contributor to the success of single-cell proteomic analysis is tissue selection. Fresh frozen has historically been favoured in omics sciences due to higher quality preservation, but it’s generally more expensive. Kelly explains that “most of our tissue work has been done with fresh frozen tissue. But there are vast resources of FFPE tissues that have been archived, and they hold the answers to many biological questions. And so, more recently, we have been working with FFPE tissues and looking at applying both nanowell-based prep and fully automated, well plate-based workflow that we call autoPOT.”

While the quality of results gathered from FFPE are not as impressive as with fresh frozen, adjustments can be made to improve them. Kelly shares his experience, noting that “if we use the same conditions that we use for fresh frozen tissue, we take a pretty big hit on coverage. But it turned out if we just increase the temperature and duration of incubation, we get to about 85% of the coverage for an equivalent tissue. And this truly is equivalent tissue, we just recently tested this using a mouse liver with half preserved by FFPE and half by fresh freezing.”

 

Conclusion and Final Thoughts

Sample preparation and tissue selection are critical to successful single-cell proteomic analysis. However, challenges remain before single-cell methods can become as common as other forms of analysis. Fortunately, leading researchers such as Kelly and his team are hard at work designing new single-cell proteomics methods.

For the most up to date information on single-cell proteomics, consider becoming an Omics Community member. Becoming a member provides access to our events as well as on-demand presentations, including Kelly’s full one hour workshop.

Speaker Biographies

Ryan Kelly – Associate Professor in the Department of Chemistry and Biochemistry at Brigham Young University

Ryan Kelly received his Ph.D. in analytical chemistry from BYU in 2005 and spent the next 13 years at Pacific Northwest National Laboratory (PNNL), where he ultimately served as Senior Research Scientist, Manager and Chief Technologist for EMSL, a national scientific user facility at PNNL. He joined the faculty of BYU in 2018. A central theme of Dr. Kelly’s research has been the development of new technological solutions for ultrasensitive biochemical analyses. He has developed ultra-low-flow electrospray ionization sources, improved MS ion optics and custom separations based on nanoflow liquid chromatography and capillary electrophoresis. Dr. Kelly’s efforts have recently focused on overcoming the losses and inefficiencies associated with sample isolation and processing of biological samples for MS-based proteomic analyses. To this end, his team developed nanoPOTS (Nanodroplet Processing in One pot for Trace Samples), which enables for the first time the in-depth profiling of protein expression from single cells and makes possible high-resolution proteome imaging of tissues. His research continues to focus on improvements in sensitivity, throughput and quantification for single-cell proteomics and other sample-limited analyses.

Share this article

Share on facebook
Share on twitter
Share on linkedin

Sign up for our monthly Omics Newsletter

You may also be interested in...

Whitepaper
The emergence of single-cell sequencing has opened a new field in analytical biological approaches particularly allowing to uncover cell-to-cell heterogeneity of 3D cellular models and preventing incomplete conclusions drawn from bulk cell populations
02 March 2022
Insight Article
Due to the heterogeneity seen in both eukaryotic and prokaryotic cell populations, single cell analysis opens up many new possibilities.
14 February 2022

Continue browsing

Share this article

Share on facebook
Share on twitter
Share on linkedin

Join our Omics mailing list

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Omics